Literature DB >> 7663052

Haematological disorders associated with feline retrovirus infections.

M L Linenberger1, J L Abkowitz.   

Abstract

Feline oncornavirus and lentivirus infections have provided useful models to characterize the virus and host cell factors involved in a variety of marrow suppressive disorders and haematological malignancies. Exciting recent progress has been made in the characterization of the viral genotypic features involved in FeLV-associated diseases. Molecular studies have clearly defined the causal role of variant FeLV env gene determinants in two disorders: the T-lymphocyte cytopathicity and the clinical acute immunosuppression induced by the FeLV-FAIDS variant and the pure red cell aplasia induced by FeLV-C/Sarma. Variant or enFeLV env sequences also appear to play a role in FeLV-associated lymphomas. Additional studies are required to determine the host cell processes that are perturbed by these variant env gene products. In the case of the FeLV-FAIDS variant, the aberrant env gene products appear to impair superinfection interference, resulting in accumulation of unintegrated viral DNA and cell death. In other cases it is likely that the viral env proteins interact with host products that are important in cell viability and/or proliferation. Understanding of these mechanisms will therefore provide insights to factors involved in normal lymphohaematopoiesis. Similarly, studies of FeLV-induced haematological neoplasms should reveal recombination or rearrangement events involving as yet unidentified host gene sequences that encode products involved in normal cell growth regulation. These sequences may include novel protoncogenes or sequences homologous to genes implicated in human haematological malignancies. The haematological consequences of FIV are quite similar to those associated with HIV. As with HIV, FIV does not appear to directly infect myeloid or erythroid precursors, and the mechanisms of marrow suppression likely involve virus, viral antigen, and/or infected accessory cells in the marrow microenvironment. Studies using in vitro experimental models are required to define the effects of each of these microenvironmental elements on haematopoietic progenitors. As little is known about the molecular mechanisms of FIV pathogenesis, additional studies of disease-inducing FIV strains are needed to identify the genotypic features that correlate with virulent phenotypic features. Finally, experimental FIV infection in cats provides the opportunity to correlate in vivo virological and haematological changes with in vitro observations in a large animal model that closely mimics HIV infection in man.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7663052      PMCID: PMC7135792          DOI: 10.1016/s0950-3536(05)80233-1

Source DB:  PubMed          Journal:  Baillieres Clin Haematol        ISSN: 0950-3536


  231 in total

1.  Distinct subsets of retroviruses encode dUTPase.

Authors:  J H Elder; D L Lerner; C S Hasselkus-Light; D J Fontenot; E Hunter; P A Luciw; R C Montelaro; T R Phillips
Journal:  J Virol       Date:  1992-03       Impact factor: 5.103

2.  Effects of feline leukemia virus infection on neutrophil chemotaxis in vitro.

Authors:  A R Kiehl; M J Fettman; S L Quackenbush; E A Hoover
Journal:  Am J Vet Res       Date:  1987-01       Impact factor: 1.156

3.  Quantitative studies of erythropoiesis in the clinically normal, phlebotomized, and feline leukemia virus-infected cat.

Authors:  K J Wardrop; J W Kramer; J L Abkowitz; G Clemons; J W Adamson
Journal:  Am J Vet Res       Date:  1986-10       Impact factor: 1.156

4.  Characterization of reverse transcriptase from feline immunodeficiency virus.

Authors:  T W North; R C Cronn; K M Remington; R T Tandberg; R C Judd
Journal:  J Biol Chem       Date:  1990-03-25       Impact factor: 5.157

5.  Structure, origin, and transforming activity of feline leukemia virus-myc recombinant provirus FTT.

Authors:  D L Doggett; A L Drake; V Hirsch; M E Rowe; V Stallard; J I Mullins
Journal:  J Virol       Date:  1989-05       Impact factor: 5.103

6.  Molecular cloning and characterization of a defective recombinant feline leukaemia virus associated with myeloid leukaemia.

Authors:  T Tzavaras; M Stewart; A McDougall; R Fulton; N Testa; D E Onions; J C Neil
Journal:  J Gen Virol       Date:  1990-02       Impact factor: 3.891

7.  Feline leukemia virus infection as a potentiating cofactor for the primary and secondary stages of experimentally induced feline immunodeficiency virus infection.

Authors:  N C Pedersen; M Torten; B Rideout; E Sparger; T Tonachini; P A Luciw; C Ackley; N Levy; J Yamamoto
Journal:  J Virol       Date:  1990-02       Impact factor: 5.103

8.  Molecular cloning of a novel isolate of feline immunodeficiency virus biologically and genetically different from the original U.S. isolate.

Authors:  T Miyazawa; M Fukasawa; A Hasegawa; N Maki; K Ikuta; E Takahashi; M Hayami; T Mikami
Journal:  J Virol       Date:  1991-03       Impact factor: 5.103

9.  Effect of human immunodeficiency virus-1 envelope glycoprotein on in vitro hematopoiesis of umbilical cord blood.

Authors:  K Sugiura; N Oyaizu; R Pahwa; V S Kalyanaraman; S Pahwa
Journal:  Blood       Date:  1992-09-15       Impact factor: 22.113

10.  Evolution of feline leukemia virus variant genomes with insertions, deletions, and defective envelope genes in infected cats with tumors.

Authors:  J L Rohn; M L Linenberger; E A Hoover; J Overbaugh
Journal:  J Virol       Date:  1994-04       Impact factor: 5.103

View more
  8 in total

1.  A putative cell surface receptor for anemia-inducing feline leukemia virus subgroup C is a member of a transporter superfamily.

Authors:  C S Tailor; B J Willett; D Kabat
Journal:  J Virol       Date:  1999-08       Impact factor: 5.103

2.  Could fetal fluid and membranes be an alternative source for mesenchymal stem cells (MSCs) in the feline species? A preliminary study.

Authors:  Eleonora Iacono; Marco Cunto; Daniele Zambelli; Francesca Ricci; Pier Luigi Tazzari; Barbara Merlo
Journal:  Vet Res Commun       Date:  2012-02-12       Impact factor: 2.459

3.  Inhibition of xenotropic murine leukemia virus-related virus by APOBEC3 proteins and antiviral drugs.

Authors:  Tobias Paprotka; Narasimhan J Venkatachari; Chawaree Chaipan; Ryan Burdick; Krista A Delviks-Frankenberry; Wei-Shau Hu; Vinay K Pathak
Journal:  J Virol       Date:  2010-03-24       Impact factor: 5.103

4.  Diminished potential for B-lymphoid differentiation after murine leukemia virus infection in vivo and in EML hematopoietic progenitor cells.

Authors:  Samantha L Finstad; Naomi Rosenberg; Laura S Levy
Journal:  J Virol       Date:  2007-04-11       Impact factor: 5.103

5.  Effects of simian betaretrovirus serotype 1 (SRV1) infection on the differentiation of hematopoietic progenitor cells (CD34+) derived from bone marrow of rhesus macaques (Macaca mulatta).

Authors:  Nestor A Montiel; Patricia A Todd; JoAnn Yee; Nicholas W Lerche
Journal:  Comp Med       Date:  2012-02       Impact factor: 0.982

Review 6.  Immunopathogenesis of feline immunodeficiency virus infection in the fetal and neonatal cat.

Authors:  Holly M Kolenda-Roberts; Leah A Kuhnt; Ryan N Jennings; Ayalew Mergia; Nazareth Gengozian; Calvin M Johnson
Journal:  Front Biosci       Date:  2007-05-01

7.  Molecular characterization and in vitro differentiation of feline progenitor-like amniotic epithelial cells.

Authors:  Lucia Rutigliano; Bruna Corradetti; Luisa Valentini; Davide Bizzaro; Aurora Meucci; Fausto Cremonesi; Anna Lange-Consiglio
Journal:  Stem Cell Res Ther       Date:  2013-10-30       Impact factor: 6.832

8.  Hemogram Findings in Cats from an Area Endemic for Leishmania infantum and Feline Immunodeficiency Virus Infections.

Authors:  Marisa Masucci; Giulia Donato; Maria Flaminia Persichetti; Vito Priolo; Germano Castelli; Federica Bruno; Maria Grazia Pennisi
Journal:  Vet Sci       Date:  2022-09-16
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.